HC-030031是TRPA1通道阻断剂,能拮抗AITC和福尔马林诱发的钙流,IC50分别为6.2 μM和5.3 μM。
HC-030031 is a selective TRPA1 channel blocker that antagonizes AITC- and formalin-evoked calcium influx with IC50 of 6.2 μM and 5.3 μM respectively.
100, 300 mg/kg 口服处理
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] McNamara CR, et al. Proc Natl Acad Sci, 2007, 104(33), 13525-13530.
[2] C.R. McNamara et al. Proc. Natl. Acad. Sci. USA 2007 104 13525 T.E. Taylor-Clark et al. Mol. Pharmacol. 2008 73 274
分子式 C18H21N5O3 |
分子量 355.39 |
CAS号 349085-38-7 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 25 mg/mL |
Water <1 mg/mL |
Ethanol <1 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT01450865 | Axonal Change, Neuronal|Pain | Drug: flupirtine | Ludwig-Maximilians - University of Munich | Phase 1 | 2009-10-01 | 2015-01-12 |
NCT02582736 | Psychotic Disorders|Schizophrenia|Schizoaffective Disorder|Bipolar Disorder|Diabetes Mellitus, Type 2 | Drug: Olanzapine|Drug: Risperidone|Drug: atypical antipsychotics (other)|Drug: typical antipsychotics | Canadian Network for Observational Drug Effect Studies, CNODES|Drug Safety and Effectiveness Network, Canada|Canadian Institutes of Health Research (CIHR) | 2012-04-01 | 2015-10-20 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们